In an op-ed published Friday, Sabin president Peter Hotez, M.D., Ph.D., and his Baylor College of Medicine colleague, William Brinkley, Ph.D., applaud the dramatic gains Texas institutions have made to become leaders among the global scientific community. They cite the routinely high ranking of public and private Texas universities as well as a voter approved amendment to start the Cancer Prevention and Research Institute of Texas (CPRIT).

2012 Albert B. Sabin Gold Medal Award Call for Nominations

November 30, 2011

The Sabin Vaccine Institute is honored to invite you to nominate a distinguished colleague for the 2012 Albert B. Sabin Gold Medal Award.

How to Nominate Your Distinguished Colleague

In order to nominate your colleague for the Gold Medal Award, provide a one-page explanation of the nominee’s most important vaccine research or advocacy contributions and why you believe they are particularly important. Please submit your nomination no later than Friday, December 16, 2011 to the following address:

Sabin

Financing research and development (R&D) for neglected tropical disease (NTDs) is a big challenge. The problem? Market failure.

The Global Network, the Sabin product development partnership (PDP) and Dr. Peter Hotez, Sabin president, were featured in a great piece on Forbes today.

Huffington Post Op-ed: A New Tropical Medicine Clinic for 'Third World America'

By Dr. Peter Hotez

Poor economic conditions have long been known to increase the risk of disease. But only recently have diseases of poverty, mostly associated with countries outside the United States, been recognized as a growing problem here at home.

Neglected tropical diseases (NTDs) might sound foreign, but they can actually be found in pockets of poverty across the U.S., most prominently in what Arianna Huffington recently called "Third World America."

In two articles published today, Dr. Peter Hotez speaks out about the burden of neglected tropical diseases (NTDs) on people living in poverty in the United States.

This article, written by Dr. Peter Hotez, president of Sabin Vaccine Institute and dean of the National School of Tropical Medicine at Baylor College of Medicine, originally appeared in TAMEST (The Academy of Medicine, Engineering and Science of Texas) e-news.

Great news in the world of global health! A recent clinical trial for an experimental malaria vaccine has yielded successful results in protecting a large number of children against malaria with minimal side effects.

Pages

Subscribe to RSS - Sabin Vaccine Development